DuPont de Nemours, Inc. logo

DuPont de Nemours, Inc. (DD)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
130. 45
-1.15
-0.8739%
$
17.55B Market Cap
37.17 P/E Ratio
3.92% Div Yield
873,351 Volume
4.3 Eps
$ 131.6
Previous Close
Analysts:
Add Transaction
Day Range
130.04 133.17
Year Range
97.34 157.98
Want to track DD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why DuPont de Nemours (DD) is a Top Momentum Stock for the Long-Term

Why DuPont de Nemours (DD) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript

DuPont de Nemours, Inc. (DD) Q2 2025 Earnings Call Transcript

DuPont de Nemours, Inc. (NYSE:DD ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Ann Giancristoforo - VP for Investor Relations Antonella B. Franzen - Senior VP & CFO Edward D.

Seekingalpha | 1 year ago
Compared to Estimates, DuPont de Nemours (DD) Q2 Earnings: A Look at Key Metrics

Compared to Estimates, DuPont de Nemours (DD) Q2 Earnings: A Look at Key Metrics

The headline numbers for DuPont de Nemours (DD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 year ago
DuPont Tops Estimates, Raises Outlook on Sales Increase, Lower Tariff Impact

DuPont Tops Estimates, Raises Outlook on Sales Increase, Lower Tariff Impact

DuPont (DD) shares rose Tuesday when the chemicals and materials manufacturer posted better-than-expected results and boosted its guidance on higher sales and volumes, plus a tax benefit. It also lowered its anticipated tariff hit.

Investopedia | 1 year ago
DuPont's Earnings & Sales Top Estimates in Q2 on Higher Volumes

DuPont's Earnings & Sales Top Estimates in Q2 on Higher Volumes

DD's Q2 earnings and sales top estimates, fueled by volume growth in ElectronicsCo and IndustrialsCo segments.

Zacks | 1 year ago
DuPont de Nemours (DD) Surpasses Q2 Earnings and Revenue Estimates

DuPont de Nemours (DD) Surpasses Q2 Earnings and Revenue Estimates

DuPont de Nemours (DD) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.97 per share a year ago.

Zacks | 1 year ago
DuPont de Nemours (DD) Earnings Expected to Grow: Should You Buy?

DuPont de Nemours (DD) Earnings Expected to Grow: Should You Buy?

DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
DuPont Launches FilmTec Hypershell for Energy-Efficient Dairy Processing

DuPont Launches FilmTec Hypershell for Energy-Efficient Dairy Processing

DuPont's FilmTec Hypershell XP RO-8038 boosts dairy processing with up to 50% more productivity or 50% less energy use.

Zacks | 1 year ago
DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant

DD Adds Sterile Packaging Capacity at Costa Rica Manufacturing Plant

DuPont's Costa Rica expansion introduces sterile healthcare packaging, a first for the region's medical device industry.

Zacks | 1 year ago
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now

Here's Why You Should Hold DuPont Stock in Your Portfolio for Now

Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.

Zacks | 1 year ago
DuPont Achieves 100% Renewable Electricity in EU Operations

DuPont Achieves 100% Renewable Electricity in EU Operations

DD hits 100% renewable electricity for EU operations, marking a major step toward its 2050 net-zero emissions goal using RECs and solar installations.

Zacks | 1 year ago
DuPont Launches AmberChrom TQ1 Resin for Biopharma Applications

DuPont Launches AmberChrom TQ1 Resin for Biopharma Applications

DD launches AmberChrom TQ1 resin, boosting oligonucleotide and peptide purification with high capacity, purity, and scalability.

Zacks | 1 year ago
Loading...
Load More